Laboratorios Goulart S.A.

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2 in Phase 3

Quick facts

Phase 3 pipeline

oxytetracycline, taro elixir · Infectious disease
Oxytetracycline is a broad-spectrum antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.
Taro Elixir
Taro Elixir's mechanism of action is not publicly available.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Laboratorios Goulart S.A. portfolio CI brief
Laboratorios Goulart S.A. pipeline updates RSS